Catalyst Capital Advisors’s Elevance Health ELV Stock Holding History

Catalyst Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,500	Closed	-$338K	–	497
2017 Q4	$338K	Buy	+1,500	New	+$319K	0.01%	214
2015 Q3	–	Sell	-35,000	Closed	-$5.75M	–	560
2015 Q2	$5.75M	Hold	35,000	–	–	0.67%	62
2015 Q1	$5.4M	Buy	35,000 +24,430	+231%	+$3.48M	0.62%	69
2014 Q4	$1.33M	Hold	10,570	–	–	0.16%	127
2014 Q3	$1.26M	Buy	+10,570	New	+$1.21M	0.16%	135

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catalyst Capital Advisors's ELV Position: Q1 2018 in Review

Catalyst Capital Advisors sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 1,500 shares — an estimated $338K sold.

Catalyst Capital Advisors first reported a position in ELV in Q3 2014 and held it in 5 quarters. The position peaked at $5.75M in Q2 2015. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

Catalyst Capital Advisors reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
Catalyst Capital Advisors sold 1,500 Elevance Health shares in Q1 2018, an estimated $338K.
Catalyst Capital Advisors first reported a position in Elevance Health in Q3 2014 and held it in 5 quarters.
Catalyst Capital Advisors's Elevance Health position peaked at $5.75M in Q2 2015.
922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Catalyst Capital Advisors's 13F filing for Q1 2018, filed 18 May 2018.